Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 50 years old
- People who have been confirmed to have mild cognitive impairment, shown by a score above 20 on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- People whose medications have not changed in the past month
- People who are able to walk independently without assistance
Who may not be able to join:
- People who have been diagnosed with dementia
- People living with a long-term mental illness, such as schizophrenia or bipolar disorder
- People who have a neurological condition or brain injury, such as multiple sclerosis, Parkinson's disease, or traumatic brain injury
- People who have been diagnosed with clinical depression, as assessed through a standard evaluation tool and medical diagnosis
- People who have had surgery recently (confirm with trial site for exact timeframe)
- People who do not have sufficient knowledge of the Greek language
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +30 6948694966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Kinematic and kinetic gait assessment; Functional Gait Assessment (FGA); mini Balance Evaluation Systems Test (mini-BESTest); Montreal Cognitive Assessment (MoCA); Cognitive Telephone Screening Instrument (COGTEL); Stroop Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.